Lehrich, Brandon M.
Delgado, Evan R.
Yasaka, Tyler M. https://orcid.org/0000-0002-8482-0369
Liu, Silvia
Cao, Catherine
Liu, Yuqing
Taheri, Mohammad N.
Guan, Xiangnan
Koeppen, Hartmut
Singh, Sucha
Meadows, Vik
Liu, Jia-Jun
Singh-Varma, Anya
Krutsenko, Yekaterina
Poddar, Minakshi
Hitchens, T. Kevin
Foley, Lesley M. https://orcid.org/0000-0001-7752-2139
Liang, Binyong
Rialdi, Alex
Rai, Ravi P.
Patel, Panari
Riley, Madeline
Bell, Aaron https://orcid.org/0000-0001-6648-0834
Raeman, Reben
Dadali, Tulin
Luke, Jason J. https://orcid.org/0000-0002-1182-4908
Guccione, Ernesto https://orcid.org/0000-0001-7764-5307
Ebrahimkhani, Mo R. https://orcid.org/0000-0001-5753-6779
Lujambio, Amaia https://orcid.org/0000-0002-2798-1481
Chen, Xin https://orcid.org/0000-0002-9588-0164
Maier, Martin https://orcid.org/0000-0002-4987-0184
Wang, Yulei https://orcid.org/0000-0002-9057-9786
Broom, Wendy
Tao, Junyan https://orcid.org/0000-0002-5249-970X
Monga, Satdarshan P. https://orcid.org/0000-0002-8437-3378
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R01CA251155, R01CA250227, F30CA284540, P30CA047904, UM1CA186690)
Article History
Received: 9 December 2024
Accepted: 21 May 2025
First Online: 30 May 2025
Competing interests
: S.P.M. has received research grants from Alnylam Pharmaceuticals. He also received funding from Fog Pharmaceuticals and is a consultant on Advisory Boards for Surrozen, AntlerA, Alnylam, Mermaid Bio, Vicero Inc., and UbiquiTx, and there is no pertinent conflict of interest of these entities as relevant to the current manuscript. T.D., M.M., and W.B. are employed by Alnylam Pharmaceuticals, Cambridge, MA. X.G., H.K., and Y.G. are employed by Genentech Inc., San Francisco, CA. No other authors have any relevant conflicts of interests to declare regarding the current study.